IDEXX Laboratories, Inc. (IDXX) PEG Ratio: 2.30
Is IDEXX Laboratories, Inc.’s PEG ratio high or low?
IDEXX Laboratories, Inc.'s PEG ratio of 2.30 is 26% below its 5-year average of 3.12, near the low end of its 5-year range (1.97–6.51).
The PEG ratio for IDEXX Laboratories, Inc. (IDXX) is 2.30. It is below its 12-month average by 47.79% (4.40).
IDXX PEG Ratio Chart
IDXX Average PEG Ratio Chart
IDXX Current vs Average PEG Ratio Chart
IDXX PEG Ratio Metrics
PEG RATIO
2.30
PEG RATIO AVG TTM
4.40
PEG RATIO AVG 3Y
3.66
PEG RATIO AVG 5Y
3.12
PEG RATIO AVG 10Y
2.76
PEG RATIO AVG 15Y
3.38
PEG RATIO AVG 20Y
3.81
CURRENT VS TTM AVG
-47.79%
CURRENT VS 3Y AVG
-37.10%
CURRENT VS 5Y AVG
-26.38%
CURRENT VS 10Y AVG
-16.79%
CURRENT VS 15Y AVG
-31.94%
CURRENT VS 20Y AVG
-39.56%
IDXX Competitors' PEG Ratio
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | — | 2.30 | 4.40 | 3.66 | 3.12 |
| Humana Inc. (HUM) | $43.60B | 0.62 | 0.45 | 0.32 | 0.59 |
| Agilent Technologies, Inc. (A) | $38.26B | 9.41 | 7.52 | 13.88 | 11.21 |
| Zoetis Inc. (ZTS) | $34.46B | 2.04 | 2.96 | 3.83 | 3.78 |
| Centene Corporation (CNC) | $32.69B | 0.01 | 0.18 | 0.16 | 0.16 |
| IQVIA Holdings Inc. (IQV) | $31.09B | 6.34 | 8.50 | 5.12 | 3.87 |
| DexCom, Inc. (DXCM) | $30.17B | 0.66 | 19.99 | 10.91 | 8.76 |
| Biogen Inc. (BIIB) | $29.39B | 0.34 | 0.34 | 0.24 | 0.23 |
| Regeneron Pharmaceuticals, Inc. (REGN) | $63.48B | 3.38 | 2.53 | 2.53 | 1.33 |
| Veeva Systems Inc. (VEEV) | $27.37B | 1.42 | 1.47 | 5.64 | 5.88 |
Growth-Adjusted Valuation
PEG Ratio
2.30
P/E Ratio
42.7
IDEXX Laboratories, Inc. PEG Ratio Formula & Definition
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IDEXX Laboratories, Inc. PEG Ratio FAQ
- What is the PEG ratio for IDEXX Laboratories, Inc. (IDXX)?
- The PEG ratio for IDXX stock is 2.30.
- Is IDEXX Laboratories, Inc.'s PEG ratio high or low?
- IDEXX Laboratories, Inc.'s PEG ratio of 2.30 is 26% below its 5-year average of 3.12, near the low end of its 5-year range (1.97–6.51).
- What is the TTM average PEG ratio for IDEXX Laboratories, Inc. (IDXX)?
- The TTM average PEG ratio for IDXX stock is 4.40.
- What is the 3Y average PEG ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 3Y average PEG ratio for IDXX stock is 3.66.
- What is the 5Y average PEG ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 5Y average PEG ratio for IDXX stock is 3.12.
- What is the 10Y average PEG ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 10Y average PEG ratio for IDXX stock is 2.76.
- What is the 15Y average PEG ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 15Y average PEG ratio for IDXX stock is 3.38.
- What is the 20Y average PEG ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 20Y average PEG ratio for IDXX stock is 3.81.
IDEXX Laboratories, Inc. PEG Ratio History
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 2.30 |
| 2024-12-31 | 6.51 |
| 2023-12-31 | 2.16 |
| 2021-12-31 | 2.68 |
| 2020-12-31 | 1.97 |
| 2019-12-31 | 3.62 |
| 2018-12-31 | 0.96 |
| 2017-12-31 | 2.43 |
| 2016-12-31 | 2.45 |
| 2015-12-31 | 2.56 |
| 2014-12-31 | 14.44 |
| 2013-12-31 | 3.25 |
| 2012-12-31 | 2.15 |
| 2011-12-31 | 1.66 |
| 2010-12-31 | 1.55 |
| 2009-12-31 | 3.56 |
| 2008-12-31 | 0.72 |
| 2007-12-31 | 14.40 |
| 2006-12-31 | 1.06 |
| 2005-12-31 | 5.68 |
| 2004-12-31 | 0.67 |
| 2003-12-31 | 1.18 |
| 2002-12-31 | 1.14 |
| 2001-12-31 | 6.81 |
| 2000-12-31 | 0.73 |
| 1998-12-31 | 2.35 |
| 1997-12-31 | 0.17 |
| 1996-12-31 | 0.55 |
Related Metrics
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jonathan J. Mazelsky